Vyondys 53
Total Payments
$2.8M
Transactions
166
Doctors
6
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $11,802 | 5 | 4 |
| 2022 | $5,313 | 1 | 0 |
| 2020 | $2.8M | 160 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.8M | 161 | 99.9% |
| Consulting Fee | $1,800 | 1 | 0.1% |
| Food and Beverage | $71.13 | 4 | 0.0% |
Payments by Type
Research
$2.8M
161 transactions
General
$1,871
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 4045-301 | Sarepta Therapeutics, Inc. | $2.8M | 1 |
| 4053-101 | Sarepta Therapeutics, Inc. | $17,043 | 0 |
Top Doctors Receiving Payments for Vyondys 53
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Minneapolis, MN | $2.8M | 159 |
| , MD | Nephrology | Miami, FL | $3,000 | 2 |
| , MD | Nephrology | New York, NY | $1,800 | 1 |
| , MD | Neurodevelopmental Disabilities | San Antonio, TX | $17.79 | 1 |
| , MD | Neurology with Special Qualifications in Child Neurology | San Antonio, TX | $17.78 | 1 |
| , MD | Neurology with Special Qualifications in Child Neurology | San Antonio, TX | $17.78 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | San Antonio, TX | $17.78 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $2.8M
- Total Doctors 6
- Transactions 166
About Vyondys 53
Vyondys 53 is a drug associated with $2.8M in payments to 6 healthcare providers, recorded across 166 transactions in the CMS Open Payments database. The primary manufacturer is Sarepta Therapeutics, Inc..
Payment data is available from 2020 to 2023. In 2023, $11,802 was paid across 5 transactions to 4 doctors.
The most common payment nature for Vyondys 53 is "Unspecified" ($2.8M, 99.9% of total).
Vyondys 53 is associated with 2 research studies, including "4045-301" ($2.8M).